Skip to main content
Premium Trial:

Request an Annual Quote

Wako Pure Chemical to Market GNI's Pathway Software in Japan

NEW YORK (GenomeWeb News) – GNI, a drug-discovery firm based in Tokyo, has tapped Wako Pure Chemical to market its biopathway imaging and modeling software in Japan, GNI said last week.
 
Beginning in April, Wako will sell GNI’s Cell Illustrator software through its partner agencies in Japan.
 
Cell Illustrator 3.0 allows biologists to create computer images and simulations of metabolic and gene regulatory pathways, signal transduction cascades, and biological interactions. GNI developed the software along with the University of Tokyo’s Institute of Medical Science to support its internal research efforts.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.